Arnold, R.; Vehns, E.; Randl, H.; Djabali, K.
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells. Int. J. Mol. Sci. 2021, 22, 7474.
https://doi.org/10.3390/ijms22147474
AMA Style
Arnold R, Vehns E, Randl H, Djabali K.
Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells. International Journal of Molecular Sciences. 2021; 22(14):7474.
https://doi.org/10.3390/ijms22147474
Chicago/Turabian Style
Arnold, Rouven, Elena Vehns, Hannah Randl, and Karima Djabali.
2021. "Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells" International Journal of Molecular Sciences 22, no. 14: 7474.
https://doi.org/10.3390/ijms22147474
APA Style
Arnold, R., Vehns, E., Randl, H., & Djabali, K.
(2021). Baricitinib, a JAK-STAT Inhibitor, Reduces the Cellular Toxicity of the Farnesyltransferase Inhibitor Lonafarnib in Progeria Cells. International Journal of Molecular Sciences, 22(14), 7474.
https://doi.org/10.3390/ijms22147474